Beta-2-microglobulin as renal diagnostic agent

Area of Science:

• Nephrology
• Clinical Chemistry

Background:

• Accurate assessment of kidney function is crucial for patient management.
• Traditional markers like serum creatinine and blood urea nitrogen have limitations.
• Radioisotopic glomerular filtration rate (GFR) is accurate but resource-intensive.

Purpose of the Study:

• To evaluate serum beta-2-microglobulin as a diagnostic marker for kidney function.
• To compare its accuracy, sensitivity, and specificity against established markers.
• To assess the cost-effectiveness of beta-2-microglobulin testing.

Main Methods:

• Serum beta-2-microglobulin levels were determined in 250 patients.
• Comparison with radioisotopic GFR, serum creatinine, and blood urea nitrogen.
• Cost-effectiveness analysis of diagnostic entities and their combinations.

Main Results:

• Serum beta-2-microglobulin demonstrated high specificity, sensitivity, and accuracy.
• The test is simple to perform and interpret.
• Cost-effectiveness analysis revealed excellent value for beta-2-microglobulin testing.

Conclusions:

• Serum beta-2-microglobulin is a reliable and efficient biomarker for assessing kidney function.
• Its favorable performance and cost-effectiveness support its integration into routine clinical practice.
• Wider clinical usage of beta-2-microglobulin is advocated for improved diagnostics.